{"id":533813,"date":"2021-09-02T08:33:27","date_gmt":"2021-09-02T12:33:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/"},"modified":"2021-09-02T08:33:27","modified_gmt":"2021-09-02T12:33:27","slug":"arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/","title":{"rendered":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences <\/b><\/p>\n<p class=\"bwalignc\"><b><i>\u2013 <\/i><\/b><i>Gastroenterology Investor Call to take place on Tuesday, September 21, 2021 at 10:30 a.m. ET<\/i><\/p>\n<p class=\"bwalignc\"><b><i>\u2013 <\/i><\/b><i>Dermatology Investor Call to take place on Monday, September 27, 2021 at 11:00 a.m. ET<\/i><\/p>\n<p>PARK CITY, Utah&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nArena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced they will be hosting two virtual R&amp;D Investor calls for analysts and investors focused on the Company\u2019s etrasimod programs. The Company will also participate in five upcoming investor conferences throughout September.\n<\/p>\n<p><b>Virtual Investor Call Webcast Information<\/b><\/p>\n<p>\nIn addition to presentations by Arena\u2019s senior management team, the investor calls will feature presentations by and Q&amp;A with renowned key opinion leaders.\n<\/p>\n<p><b>Gastroenterology Investor Call<\/b><\/p>\n<p>\nPresenters:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nRobert Lisicki, Executive Vice President and Chief Commercial Officer, Arena Pharmaceuticals\n<\/li>\n<li>\nWilliam Sandborn, MD, Distinguished Professor of Medicine; University of California San Diego\n<\/li>\n<\/ul>\n<p>\nThe video webcast will be broadcast live in listen-only mode from 10:30 a.m. ET to 11:30 a.m. ET on Tuesday, September 21, 2021. Register for the event <b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fonlinexperiences.com%2FLaunch%2FQReg%2FShowUUID%3D0826913A-3481-4412-95E7-002753662478&amp;esheet=52485495&amp;newsitemid=20210902005205&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=5dc0c789c2446c95fbf7a6ad3b1be3f4\">here<\/a><\/b>. An archived webcast of the call will be available on the <b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvest.arenapharm.com%2F&amp;esheet=52485495&amp;newsitemid=20210902005205&amp;lan=en-US&amp;anchor=investor+relations&amp;index=2&amp;md5=9ef5d587bda25b57a8fda96eeb98aabe\">investor relations<\/a><\/b> section of Arena&#8217;s website at <b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.arenapharm.com%2F&amp;esheet=52485495&amp;newsitemid=20210902005205&amp;lan=en-US&amp;anchor=www.arenapharm.com&amp;index=3&amp;md5=6330545ebceac4775da9cb978ebd1751\">www.arenapharm.com<\/a><\/b>.\n<\/p>\n<p><b>Dermatology Investor Call<\/b><\/p>\n<p>\nPresenters:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nDoug Manion, MD, Executive Vice President, Head of Research and Development, Arena Pharmaceuticals\n<\/li>\n<li>\nJonathan Silverberg, MD, PhD, MPH, Associate Professor, Director of Clinical Research; George Washington University School of Medicine and Health Sciences\n<\/li>\n<\/ul>\n<p>\nThe video webcast will be broadcast live in listen-only mode from 11:00 a.m. ET to 12:00 p.m. ET on Monday, September 27, 2021. Register for the event <b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fonlinexperiences.com%2FLaunch%2FQReg%2FShowUUID%3D7639D696-7B15-452B-8522-E1C43E7F962D&amp;esheet=52485495&amp;newsitemid=20210902005205&amp;lan=en-US&amp;anchor=here&amp;index=4&amp;md5=2b0cc9750e690cb95ba8a0b2aedd0d23\">here<\/a><\/b>. An archived webcast of the call will be available on the <b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvest.arenapharm.com%2F&amp;esheet=52485495&amp;newsitemid=20210902005205&amp;lan=en-US&amp;anchor=investor+relations&amp;index=5&amp;md5=11be1ff3eebd54ace6fa93572fea97ae\">investor relations<\/a><\/b> section of Arena&#8217;s website at <b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.arenapharm.com%2F&amp;esheet=52485495&amp;newsitemid=20210902005205&amp;lan=en-US&amp;anchor=www.arenapharm.com&amp;index=6&amp;md5=dbb9d5dd1b99ef5d5716c19563543621\">www.arenapharm.com<\/a><\/b>.\n<\/p>\n<p><b>September Investor Conferences<\/b><\/p>\n<p>\nArena management will provide an overview of the Company during investor meetings and presentations at five upcoming investor conferences:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nCiti 2021 BioPharma Virtual Conference \u2013 September 9th\n<\/li>\n<li>\nWells Fargo Virtual Healthcare Conference \u2013 September 10th\n<\/li>\n<li>\nH.C. Wainwright 23rd Annual Global Investment Conference \u2013 September 13th &amp; 14th\n<\/li>\n<li>\nMorgan Stanley Global Healthcare Conference \u2013 September 15th\n<\/li>\n<li>\nCantor Fitzgerald Virtual Global Healthcare Conference \u2013 September 28th &amp; 29th\n<\/li>\n<\/ul>\n<p><b>About Etrasimod<\/b><\/p>\n<p>\nEtrasimod (APD334) is a next generation, once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator discovered by Arena and designed for optimized pharmacology and engagement of S1P receptors 1, 4, and 5, which may lead to an improved efficacy and safety profile. Etrasimod is intended to provide systemic and local effects on specific immune cell types and has the potential to treat multiple immune-mediated inflammatory diseases including ulcerative colitis, Crohn\u2019s disease, eosinophilic esophagitis, atopic dermatitis, and alopecia areata.\n<\/p>\n<p>\nEtrasimod is an investigational compound that is not approved for any use in any country.\n<\/p>\n<p><b>About Arena Pharmaceuticals<\/b><\/p>\n<p>\nARENA Pharmaceuticals is a team with a singular purpose \u2013 deliver important medicines to patients.\n<\/p>\n<p>\nIn a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get medicines to patients, and relentlessly execute until it&#8217;s done.\n<\/p>\n<p>\nWe are developing a richly diversified portfolio of therapeutic candidates targeting gastroenterology, dermatology and cardiology. To fuel our growth, we are unlocking the value of our historical GPCR research with a sustainable discovery engine for broad portfolio expansion.\n<\/p>\n<p>\nARENA &#8211; <i>Care More. Act Differently.<\/i><\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements may be identified by words such as \u201cdesigned for,\u201d \u201cmay,\u201d \u201clead to,\u201d \u201cintended,\u201d and \u201cpotential to,\u201d and include, without limitation, statements about the potential benefits of etrasimod, and Arena\u2019s purpose, work, understanding, ideas, and execution. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena\u2019s expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: topline data may not accurately reflect the complete results of a particular study or trial; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; the timing and outcome of research, development and regulatory review is uncertain, and Arena\u2019s drug candidates may not advance in development or be approved for marketing; enrolling patients in Arena\u2019s ongoing and intended clinical trials is competitive and challenging; the duration and severity of the coronavirus disease (COVID-19) pandemic, including but not limited to the impact on Arena\u2019s clinical operations, the operations of Arena\u2019s suppliers, partners, collaborators, licensees, and capital markets, which in each case remains uncertain; risks related to developing and commercializing drugs; Arena will need additional funds to advance all of its programs; the impact of competition; risks related to unexpected or unfavorable new data; the risk that regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; satisfactory resolution of litigation or other disagreements with others; and risks related to the enforcement of Arena\u2019s and third parties\u2019 intellectual property rights. Additional factors that could cause actual results to differ materially from those stated or implied by Arena\u2019s forward-looking statements are disclosed in Arena\u2019s filings with the Securities and Exchange Commission (SEC), including but not limited to Arena\u2019s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, which was filed with the SEC on August 5, 2021. These forward-looking statements represent Arena\u2019s judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210902005205\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210902005205\/en\/<\/a><\/span><\/p>\n<p><b>Corporate Contacts:<br \/>\n<\/b><br \/>Patrick Malloy<br \/>\n<br \/>Arena Pharmaceuticals, Inc.<br \/>\n<br \/>Vice President, Investor Relations &amp; Corporate Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:pmalloy@arenapharm.com\">pmalloy@arenapharm.com<br \/>\n<\/a><br \/>847.987.4878\n<\/p>\n<p>\nSara Doran<br \/>\n<br \/>Arena Pharmaceuticals, Inc.<br \/>\n<br \/>Associate Director, Investor Relations &amp; Corporate Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:sdoran@arenapharm.com\">sdoran@arenapharm.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Utah<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Cardiology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210902005205\/en\/1036868\/3\/ARENA_Logo_CMAD_Tag_RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences \u2013 Gastroenterology Investor Call to take place on Tuesday, September 21, 2021 at 10:30 a.m. ET \u2013 Dermatology Investor Call to take place on Monday, September 27, 2021 at 11:00 a.m. ET PARK CITY, Utah&#8211;(BUSINESS WIRE)&#8211; Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced they will be hosting two virtual R&amp;D Investor calls for analysts and investors focused on the Company\u2019s etrasimod programs. The Company will also participate in five upcoming investor conferences throughout September. Virtual Investor Call Webcast Information In addition to presentations by Arena\u2019s senior management team, the investor calls will feature presentations by and Q&amp;A with renowned key opinion leaders. Gastroenterology Investor Call &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533813","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences \u2013 Gastroenterology Investor Call to take place on Tuesday, September 21, 2021 at 10:30 a.m. ET \u2013 Dermatology Investor Call to take place on Monday, September 27, 2021 at 11:00 a.m. ET PARK CITY, Utah&#8211;(BUSINESS WIRE)&#8211; Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced they will be hosting two virtual R&amp;D Investor calls for analysts and investors focused on the Company\u2019s etrasimod programs. The Company will also participate in five upcoming investor conferences throughout September. Virtual Investor Call Webcast Information In addition to presentations by Arena\u2019s senior management team, the investor calls will feature presentations by and Q&amp;A with renowned key opinion leaders. Gastroenterology Investor Call &hellip; Continue reading &quot;Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T12:33:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences\",\"datePublished\":\"2021-09-02T12:33:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/\"},\"wordCount\":1038,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/\",\"name\":\"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-02T12:33:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences - Market Newsdesk","og_description":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences \u2013 Gastroenterology Investor Call to take place on Tuesday, September 21, 2021 at 10:30 a.m. ET \u2013 Dermatology Investor Call to take place on Monday, September 27, 2021 at 11:00 a.m. ET PARK CITY, Utah&#8211;(BUSINESS WIRE)&#8211; Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced they will be hosting two virtual R&amp;D Investor calls for analysts and investors focused on the Company\u2019s etrasimod programs. The Company will also participate in five upcoming investor conferences throughout September. Virtual Investor Call Webcast Information In addition to presentations by Arena\u2019s senior management team, the investor calls will feature presentations by and Q&amp;A with renowned key opinion leaders. Gastroenterology Investor Call &hellip; Continue reading \"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T12:33:27+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences","datePublished":"2021-09-02T12:33:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/"},"wordCount":1038,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/","name":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-02T12:33:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005205r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/arena-pharmaceuticals-to-host-virtual-rd-investor-calls-and-participate-in-upcoming-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Arena Pharmaceuticals to Host Virtual R&amp;D Investor Calls and Participate in Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533813"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533813\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}